Showing results (221-230 of 270) with videos related to

Sort By:
Pageof 27
Nutrients|May 28, 2022
Current Hydration Habits: The Disregarded Factor for the Development of Renal and Cardiometabolic DiseasesRichard J Johnson, Fernando E García-Arroyo, Guillermo Gonzaga-Sánchez, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of 5'-deoxy-5-fluorouridine (doxifluridine) in advanced malignant melanomaP Alberto, M Rozencweig, M Clavel, et al.
JCI Insight|December 15, 2020
Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptorAna Andres-Hernando, Thomas J Jensen, Masanari Kuwabara, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1988
A randomized comparison of doxifluridine and fluorouracil in colorectal carcinomaP Alberto, B Mermillod, G Germano, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1983
Randomized trial of 3 different regimens of combination chemotherapy in patients receiving simultaneously a hormonal treatment for advanced breast cancerF Cavalli, A Pedrazzini, G Martz, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 4, 2018
Upregulation of CD80 on glomerular podocytes plays an important role in development of proteinuria following pig-to-baboon xeno-renal transplantation - an experimental studyChristopher J Rivard, Tatsu Tanabe, Miguel A Lanaspa, et al.
American Journal of Physiology. Renal Physiology|July 29, 2016
Aging-associated renal disease in mice is fructokinase dependentCarlos A Roncal-Jimenez, Takuji Ishimoto, Miguel A Lanaspa, et al.
Plos One|November 1, 2012
Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liverMiguel A Lanaspa, Laura G Sanchez-Lozada, Christina Cicerchi, et al.
Schweizerische Medizinische Wochenschrift|May 29, 1982
[Simultaneous or sequential hormono/chemotherapy and a comparison of various polychemotherapies in the treatment of metastatic breast cancer]F Cavalli, M Beer, G Martz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 1993
"Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK)C Hürny, J Bernhard, R Joss, et al.
Pageof 27